Heron Therapeutics Inc. | Mutual Funds
Mutual Funds that own Heron Therapeutics Inc.
Fidelity Growth Company Fund
2,707,492
3.48%
-40,731
0.22%
07/31/2018
SPDR S&P Biotech ETF
2,405,984
3.1%
6,189
1.58%
09/06/2018
Janus Triton Fund
2,347,401
3.02%
0
0.77%
06/30/2018
Vanguard Total Stock Market Index Fund
1,734,064
2.23%
1,610
0.01%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,712,420
2.2%
-639,500
2.84%
06/30/2018
Franklin Biotechnology Discovery Fund
1,511,677
1.95%
-269,346
4%
03/31/2018
Fidelity Select Biotechnology Portfolio
1,411,479
1.82%
291,400
0.59%
07/31/2018
iShares Russell 2000 ETF
1,340,726
1.73%
-717
0.11%
09/06/2018
Eagle Small Cap Growth Fund
1,274,695
1.64%
1,274,695
0.85%
06/29/2018
Fidelity OTC Portfolio
1,252,815
1.61%
0
0.22%
07/31/2018
| Address |
4242 Campus Point Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.herontx.com |
| Updated |
07/08/2019 |
| Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. |
